Bovilis Nasalgen-C

RSS

Authorised

This medicine is authorised for use in the European Union

bovine coronavirus, strain CA25, live
MedicineVeterinaryAuthorised

Lithuanian is available via eTranslation, the European Commission's machine translation service.

Translate to Lithuanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

Name of medicine
Bovilis Nasalgen-C
Active substance
bovine coronavirus, strain CA25, live
International non-proprietary name (INN) or common name
bovine coronavirus, strain CA25, live

Pharmacotherapeutic group

  • Immunologicals for Bovidae
  • Live viral vaccines
  • bovine coronavirus

Authorisation details

EMA product number
EMEA/V/C/005906

Assessment history

CVMP summary of positive opinion for Bovilis Nasalgen-C

Adopted Reference Number: EMA/CVMP/42050/2023

English (EN) (127.29 KB - PDF)

Pirmą kartą paskelbta:
Rodyti
This page was last updated on

Share this page